Mazdutide 10 MG

The Dual GLP-1/Glucagon Agonist Peptide is a synthetic unimolecular peptide engineered to target both the glucagon-like peptide-1 receptor (GLP-1R) and the glucagon receptor (GCGR). Primarily researched in Asia, especially China, this peptide is studied for its potential effects on obesity, type 2 diabetes, and related metabolic and cardiovascular conditions. It combines the beneficial actions of GLP-1 and glucagon receptor activation to support body weight management, enhance glucose metabolism, and reduce cardio-metabolic risks.

Research involving this peptide explores:

• Its efficacy in reducing body weight and improving glucose control in animal models and clinical trials for obesity and diabetes.
• Neuroprotective effects in diabetic and obese models, including enhancement of cognitive function and reduction of neurodegenerative pathology.
• Regulation of amino acid and lipid metabolism, oxidative phosphorylation, and glutathione metabolism, contributing to improved neuronal energy and systemic metabolic health.
• The dual receptor activation mechanism integrating central and peripheral pathways affecting energy balance, insulin sensitivity, and lipid metabolism.
• Safety and tolerability profiles comparable to other GLP-1 receptor agonists, supporting its development as a once-weekly treatment candidate.

The Dual GLP-1/Glucagon Agonist Peptide is supplied as a research peptide compound for laboratory use only. It is undergoing clinical evaluation for weight and glucose regulation and is not intended for human or veterinary use. For Research Use Only.

Product details:

• Synonyms:  IBI362, LY3305677
• Purity: Research-grade
• Molecular Weight: Approximately 4560 Da
• Appearance: White to off-white lyophilized powder

This product is intended exclusively for scientific research and laboratory investigation and is not for diagnostic or therapeutic use in humans or animals.